This inventor holds 1 USPTO granted patent. Top assignee: Amira Pharmaceuticals, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Inventor Wang Bowei: Advancing Pharmaceutical Innovations
Introduction: Wang Bowei, an innovative inventor based in Westfield, NJ, has made significant contributions to the field of pharmaceuticals. With one patent to his name, he focuses on compounds that act as antagonists of lysophosphatidic acid receptors, aiming to enhance treatment options for various medical conditions.
Latest Patents: Wang Bowei's notable patent is titled "Compounds as lysophosphatidic acid receptor antagonists." This patent details compounds that serve as antagonists to lysophosphatidic receptors. Furthermore, it describes pharmaceutical compositions and medicaments incorporating these compounds, along with methods for their application in treating lysophosphatidic acid-dependent or mediated diseases and conditions.
Career Highlights: Currently, Wang Bowei is affiliated with Amira Pharmaceuticals, Inc., a company dedicated to delivering breakthrough therapeutic solutions. His work there emphasizes the development of innovative treatments aimed at addressing complex health issues through the discovery of new pharmaceutical compounds.
Collaborations: Throughout his career, Wang has collaborated with esteemed colleagues, including John Howard Hutchinson and Thomas Jon Seiders. These partnerships reflect a commitment to advancing scientific knowledge and improving healthcare outcomes through teamwork and shared expertise.
Conclusion: Wang Bowei stands out as a prominent inventor in the pharmaceutical industry, leveraging his innovative insights to address critical health challenges. His contributions, highlighted by his patent on lysophosphatidic acid receptor antagonists, underscore the importance of ongoing research and collaboration in developing effective treatments for patients in need.